Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma (COLUMBUS)

Clinical Trial ID NCT01909453

PubWeight™ 11.58^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01909453

Top papers